Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
01.10.25
/
50%
€115.08
Target price
01.10.26
€133.73
Performance (%)
-25.70%
Price
10.04.26
€85.50
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -25.70%. This prediction currently runs until 01.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $153.00 to $157.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€87.50
08.04.26
08.04.26
€103.67
08.04.27
08.04.27
-2.29%
10.04.26
10.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€92.26
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
-7.33%
10.04.26
10.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.22
15.01.26
15.01.26
€130.60
15.01.27
15.01.27
-17.61%
10.04.26
10.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-26.88%
05.03.26
05.03.26